Brunswick Corporation
BC
$80.45
-4.19%
Brunswick Corporation is a leading manufacturer in the marine recreation industry, operating across propulsion, boats, parts, and accessories. It is defined by its portfolio of over 60 brands and ownership of the Freedom Boat Club, positioning it as an integrated player focused on innovative marine experiences and technologies.…
BC
Brunswick Corporation
$80.45
Related headlines
Investment Opinion: Should I buy BC Today?
Based on a synthesis of the data, the objective assessment for Brunswick Corporation (BC) is a Hold. The valuation appears reasonable with a forward P/E of 13.3 and a PS ratio below 1, and the company generates strong free cash flow. However, these positives are counterbalanced by inconsistent earnings, high financial leverage, and recent underperformance. The mixed analyst sentiment, with a blend of Buy and Neutral ratings, supports this cautious stance. Investors should await more consistent profitability and a clearer technical bottom before considering a new position.
Sign up to view all
BC 12-Month Price Forecast
The analysis yields a neutral stance due to conflicting signals: attractive valuation and cash flow versus poor earnings quality and high leverage. The path forward depends heavily on the company's ability to stabilize its bottom line.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Brunswick Corporation's 12-month outlook, with a consensus price target around $104.59 and implied upside of +30.0% versus the current price.
Average Target
$104.59
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$64 - $105
Analyst target range
Wall Street analyst coverage for Brunswick is limited, with data from only 4 analysts. The consensus estimates an average EPS of $6.47 and average revenue of approximately $6.38 billion for the period in view. Recent institutional ratings show a mix of Buy and Neutral/Hold actions, with firms like Citigroup, Roth Capital, and Benchmark maintaining Buy ratings, while others like JP Morgan and DA Davidson have Neutral stances. Specific consensus target price data is not available.
Bulls vs Bears: BC Investment Factors
Brunswick presents a mixed investment case. Bullish factors include strong revenue growth, solid free cash flow, and a seemingly undervalued sales multiple. However, significant bearish concerns center on inconsistent profitability, high leverage, and weak recent stock performance amidst broader market volatility.
Bullish
- Strong Revenue Growth: Q4 2025 revenue grew 15.5% YoY, indicating robust demand.
- Healthy Free Cash Flow: TTM FCF of $396.3M provides financial flexibility and liquidity.
- Undervalued on Sales Basis: PS ratio of 0.91 suggests the stock trades below its revenue value.
- Analyst EPS Expectations: Forward P/E of 13.3 reflects expectations for a return to solid profitability.
Bearish
- Inconsistent Profitability: Negative TTM EPS and volatile quarterly income show earnings instability.
- High Financial Leverage: Debt-to-equity of 1.49 indicates a leveraged balance sheet.
- Weak Recent Performance: Stock down 12.6% over past month, underperforming the market.
- Negative Shareholder Returns: Negative ROE of -8.45% shows poor returns on equity.
BC Technical Analysis
The stock's overall trend over the past six months shows significant volatility with a net gain of 8.47%, climbing from around $64 in October 2025 to a peak near $89 in February 2026 before a sharp correction. Short-term performance has been weak, with the stock declining 12.64% over the past month and 7.29% over the past three months, underperforming the broader market's 3-month decline of 7.32%. The current price of $69.56 sits near the middle of its 52-week range ($41.00 - $90.25), representing a pullback of approximately 23% from its recent high, indicating it is in a corrective phase after a strong rally earlier in the period.
Beta
1.38
1.38x market volatility
Max Drawdown
-27.5%
Largest decline past year
52-Week Range
$44-$90
Price range past year
Annual Return
+79.5%
Cumulative gain past year
| Period | BC Return | S&P 500 |
|---|---|---|
| 1m | +8.6% | +8.5% |
| 3m | -8.5% | +3.2% |
| 6m | +11.9% | +5.0% |
| 1y | +79.5% | +34.9% |
| ytd | +6.0% | +4.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BC Fundamental Analysis
Revenue in Q4 2025 was $1.33 billion, showing a 15.5% year-over-year growth from the same quarter in 2024. However, profitability is inconsistent, with the latest quarterly net income at $18.7 million (net margin of 1.4%) but a trailing twelve-month EPS of -$0.028, indicating periods of loss. Financial health shows a debt-to-equity ratio of 1.49, indicating a leveraged balance sheet, but the company maintains a current ratio of 1.44 and generated $396.3 million in TTM free cash flow, suggesting adequate liquidity. Operational efficiency metrics are mixed, with a negative Return on Equity (ROE) of -8.45% and a positive Return on Assets (ROA) of 3.56%, pointing to challenges in translating assets into shareholder returns despite some asset productivity.
Quarterly Revenue
$1.3B
2025-12
Revenue YoY Growth
+0.15%
YoY Comparison
Gross Margin
+0.23%
Latest Quarter
Free Cash Flow
$396300000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BC Overvalued?
Given the company's negative trailing twelve-month net income, the Price-to-Sales (PS) ratio is a more appropriate valuation metric than the P/E ratio. Brunswick trades at a PS ratio of 0.91 and an Enterprise Value-to-Sales (EV/Sales) ratio of 1.22, which suggests the market is valuing its revenue stream at less than 1x. The forward P/E ratio based on analyst estimates is 13.3, indicating expectations for a return to profitability. Peer comparison data is not available in the provided inputs.
PE
-35.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -13x~65x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
26.2x
Enterprise Value Multiple
Investment Risk Disclosure
Brunswick faces several material risks. Financially, the company carries significant leverage with a debt-to-equity ratio of 1.49, which could strain cash flows if interest rates rise or earnings decline. The inconsistent profitability, evidenced by a negative TTM net margin and volatile quarterly results from a large loss in Q3 2025 to a profit in Q4, points to operational execution risks and potential cost control issues. As a consumer cyclical company in the marine industry, BC is highly exposed to macroeconomic downturns that reduce discretionary spending on boats and recreational vehicles. The stock's high beta of 1.376 indicates it is 38% more volatile than the market, amplifying downside risk during bear markets. Furthermore, the sharp 23% pullback from its recent 52-week high demonstrates investor skittishness and the potential for continued technical weakness.
FAQ
The key risks include high financial leverage (debt-to-equity of 1.49), inconsistent profitability with a negative ROE of -8.45%, and sensitivity to economic cycles as a consumer discretionary company. The stock's high beta of 1.376 also means it is likely to experience greater volatility than the overall market, especially during downturns.
The 12-month outlook is mixed with a base case target range of $70-$80, representing modest upside from the current ~$69.56. The bull case (30% probability) targets $85-$90 on strong earnings execution, while the bear case (20% probability) could see a decline to $50-$65 if macroeconomic conditions worsen. The consensus view is neutral with a wide range of potential outcomes.
BC's valuation sends mixed signals. It appears undervalued based on sales, trading at a PS ratio of 0.91 and an EV/Sales of 1.22. However, it is difficult to assess on an earnings basis due to negative TTM profits. The forward P/E of 13.3, based on analyst estimates, suggests the market is pricing in a return to reasonable profitability, making the stock fairly valued for now.
Based on current data, BC is not a compelling buy. While its Price-to-Sales ratio of 0.91 suggests it is not overvalued, the company's negative trailing EPS and inconsistent quarterly profits create significant uncertainty. The stock has also underperformed recently, falling over 12% in the past month. A 'Hold' rating is more appropriate until profitability stabilizes.
BC is not suitable for short-term trading due to its high volatility and lack of a clear near-term catalyst. For long-term investors, it could be a speculative hold if one believes management can fix the profitability issues and leverage its market position. However, the inconsistent financial performance makes it a higher-risk, turnaround story rather than a stable long-term compounder.
